This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet). Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Juan Bayo: Innovator in Cancer Treatment
Introduction
Juan Bayo is a notable inventor based in Belen de Escobar, Argentina. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on enhancing the migration of mesenchymal stromal cells to tumors, which has the potential to improve therapeutic outcomes for cancer patients.
Latest Patents
Juan Bayo holds a patent for "Compositions and methods for increasing mesenchymal stromal cell migration to tumors." This patent outlines compositions and methods aimed at treating subjects with cancer by increasing the migration of mesenchymal stromal cells (MSCs) to tumors, such as hepatocellular carcinoma (HCC). The methods also include increasing the adhesion of MSCs to endothelial cells using a recombinant autocrine motility factor (rAMF). In some cases, the MSCs may carry a therapeutic agent, such as an anti-tumor agent.
Career Highlights
Throughout his career, Juan Bayo has worked with esteemed organizations, including the National Scientific and Technical Research Council (CONICET) and the Civil Association of Higher Studies. His research has contributed to advancements in cancer therapies and has positioned him as a key figure in the scientific community.
Collaborations
Juan has collaborated with notable colleagues, including Guillermo Daniel Mazzolini and Mariana Gabriela Garcia. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.
Conclusion
Juan Bayo's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his dedication to advancing medical science. His work continues to inspire future research in the field of oncology.